New Combined Treatment Improves Heart Function in CTEPH Cases
A new sequential strategy successfully treats people with severe chronic thromboembolic pulmonary hypertension (CTEPH), significantly reducing high blood pressure and improving heart function, a study finds.
The three-step regimen consists of medication, followed by balloon pulmonary angioplasty (BPA), and then pulmonary endarterectomy (PEA) surgery. This approach is designed for individuals facing unacceptably high surgical risk and complex blood clot locations.
- Medication as the initial treatment
- Balloon pulmonary angioplasty (BPA) as the second step
- Pulmonary endarterectomy (PEA) surgery as the final step
When followed, this regimen significantly reduced blood pressure in the pulmonary arteries and a marker of heart failure, improved functionality, and led to a 95% survival rate, the data showed.
A study by Steve Bryson, PhD, on October 13, 2025, reveals the effectiveness of this combined treatment approach.
Author's summary: New treatment improves heart function in CTEPH cases.